AREIT Fundamental Analysis - ALTAREIT

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to AREIT. AREIT was compared to 70 industry peers in the Real Estate Management & Development industry. The financial health of AREIT is average, but there are quite some concerns on its profitability. AREIT does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

AREIT had negative earnings in the past year.

AREIT had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: AREIT reported negative net income in multiple years.

Of the past 5 years AREIT 4 years had a positive operating cash flow.

1.2 Ratios

AREIT's Return On Assets of -1.84% is on the low side compared to the rest of the industry. AREIT is outperformed by 60.00% of its industry peers.

AREIT has a worse Return On Equity (-8.22%) than 64.29% of its industry peers.

The Return On Invested Capital of AREIT (1.02%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-1.84%
ROE	-8.22%
ROIC	1.02%

ROA(3y)-2.85%

ROA(5y)-1.06%

ROE(3y)-14.56%

ROE(5y)-5.87%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 0.93%, AREIT is in line with its industry, outperforming 41.43% of the companies in the same industry.

AREIT's Operating Margin has declined in the last couple of years.

AREIT has a Gross Margin of 16.64%. This is in the lower half of the industry: AREIT underperforms 62.86% of its industry peers.

AREIT's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	0.93%
PM (TTM)	N/A
GM	16.64%

OM growth 3Y-50.62%

OM growth 5Y-32.09%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.03%

GM growth 5Y-5.31%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AREIT is destroying value.

Compared to 1 year ago, AREIT has about the same amount of shares outstanding.

The number of shares outstanding for AREIT remains at a similar level compared to 5 years ago.

The debt/assets ratio for AREIT is higher compared to a year ago.

2.2 Solvency

AREIT has an Altman-Z score of 1.40. This is a bad value and indicates that AREIT is not financially healthy and even has some risk of bankruptcy.

AREIT has a Altman-Z score of 1.40. This is in the better half of the industry: AREIT outperforms 71.43% of its industry peers.

AREIT has a debt to FCF ratio of 4.57. This is a neutral value as AREIT would need 4.57 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 4.57, AREIT belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.

A Debt/Equity ratio of 0.96 indicates that AREIT is somewhat dependend on debt financing.

AREIT's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. AREIT is outperformed by 62.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	4.57
Altman-Z	1.4

ROIC/WACC0.17

WACC5.92%

2.3 Liquidity

AREIT has a Current Ratio of 1.22. This is a normal value and indicates that AREIT is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of AREIT (1.22) is comparable to the rest of the industry.

A Quick Ratio of 0.74 indicates that AREIT may have some problems paying its short term obligations.

With a Quick ratio value of 0.74, AREIT perfoms like the industry average, outperforming 48.57% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.22
Quick Ratio	0.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.00% over the past year.

AREIT shows a decrease in Revenue. In the last year, the revenue decreased by -6.91%.

AREIT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.00% yearly.

EPS 1Y (TTM)82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%22.86%

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-4.16%

Revenue growth 5Y-3%

Sales Q2Q%-23.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AREIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AREIT is on the same level as its industry peers.

Based on the Price/Free Cash Flow ratio, AREIT is valued cheaper than 81.43% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	5.38
EV/EBITDA	20.86

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AREIT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALTAREIT

EPA:AREIT (8/29/2025, 7:00:00 PM)

555

0 (0%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)07-29 2025-07-29

Earnings (Next)02-23 2026-02-23

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners99.85%

Ins Owner ChangeN/A

Market Cap971.25M

Analysts78

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.44
P/FCF	5.38
P/OCF	4.06
P/B	1.36
P/tB	2.54
EV/EBITDA	20.86

EPS(TTM)-33.52

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)103.09

FCFY18.57%

OCF(TTM)136.86

OCFY24.66%

SpS1269.89

BVpS407.6

TBVpS218.34

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.84%
ROE	-8.22%
ROCE	1.65%
ROIC	1.02%
ROICexc	1.17%
ROICexgc	1.57%
OM	0.93%
PM (TTM)	N/A
GM	16.64%
FCFM	8.12%

ROA(3y)-2.85%

ROA(5y)-1.06%

ROE(3y)-14.56%

ROE(5y)-5.87%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y-39.13%

ROICexcg growth 5Y-24.87%

ROICexc growth 3Y-44.01%

ROICexc growth 5Y-28.25%

OM growth 3Y-50.62%

OM growth 5Y-32.09%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.03%

GM growth 5Y-5.31%

F-Score6

Asset Turnover0.7

Health

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	4.57
Debt/EBITDA	10.34
Cap/Depr	130.75%
Cap/Sales	2.66%
Interest Coverage	0.3
Cash Conversion	363.43%
Profit Quality	N/A
Current Ratio	1.22
Quick Ratio	0.74
Altman-Z	1.4

F-Score6

WACC5.92%

ROIC/WACC0.17

Cap/Depr(3y)26.41%

Cap/Depr(5y)37.36%

Cap/Sales(3y)0.42%

Cap/Sales(5y)0.45%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%22.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-4.16%

Revenue growth 5Y-3%

Sales Q2Q%-23.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y106.53%

EBIT growth 3Y-52.68%

EBIT growth 5Y-34.13%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y76.86%

FCF growth 3Y76.04%

FCF growth 5Y6.06%

OCF growth 1Y126.59%

OCF growth 3Y70.6%

OCF growth 5Y7.85%

ALTAREIT (AREIT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens